COMP <GO>
DOC vs HSBC // REVENUE GROWTH (YOY)
Healthpeak Properties Inc. (NYSE) VS. HSBC Holdings plc. (NYSE) • 15-METRIC TALLY: DOC 6
— HSBC 7
▲ REVENUE GROWTH (YOY) LEADER: HSBC
LAST: $19.03 (+0.48%) • MKT CAP: $13.06B
revenue-growth
6.20%
LAST: $85.42 (-1.36%) • MKT CAP: $297.33B
revenue-growth
23.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DOC VS. HSBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DOC | HSBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 41.00% | 0.00 | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.60% | 9.90% | -9.30 | HSBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 95.0x | 21.0x | +74.00 | HSBC | /valuation <GO> |
| Free Cash Flow Yield | 9.38% | 2.21% | +7.17 | DOC | /fcf-yield <GO> |
| Operating Margin | 14.40% | 13.90% | +0.50 | DOC | /operating-margins <GO> |
| Net Profit Margin | 11.80% | 10.90% | +0.90 | DOC | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 6.20% | 23.10% | -16.90 | HSBC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.50% | 0.00% | +6.50 | DOC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.12 | 3.74 | -2.62 | HSBC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.60% | +0.40 | HSBC | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.9 | 25.0 | +21.89 | DOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.92 | +0.10 | DOC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 27.6x | +112.40 | HSBC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.06B | $297.33B | -$284.27B | HSBC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DOC REV | HSBC REV | DOC GROSS % | HSBC GROSS % | DOC FCF | HSBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $604.0M | — | 44.0% | — | $1.22B | — |
| FY 2024 | $568.5M | — | -89.1% | — | $1.04B | — |
| FY 2023 | $527.4M | — | 44.0% | — | $932.5M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DOC // BETA 1.02
HSBC // BETA 0.92